Abnormal Peripheral Neutrophil Transcriptome in Newly Diagnosed Type 2 Diabetes Patients
Table 3
Clinical and biochemical characteristics of the study participants for validation.
HC ()
T2D ()
value
Sex (male/female)
8 (6/2)
8 (6/2)
1.000
Age (years)
0.496
BMI (kg/m2)
0.273
WHR
0.388
DBP (mmHg)
0.316
SBP (mmHg)
0.733
TG (mmol/L)
0.903
TC (mmol/L)a
4.77 (4.05~4.93)
3.96 (2.50~4.56)
0.050
HDL-C (mmol/L)
0.332
LDL-C (mmol/L)
0.065
HbA1c (%)a
5.30 (5.20~5.55)
6.50 (6.05~7.70)
<0.001
Fasting BS (mmol/L)a
4.61 (4.21~5.11)
5.97 (5.14~7.65)
0.002
2 h postprandial BS (mmol/L)
<0.001
Fasting C-peptide (pmol/L)
0.420
2 h postprandial C-peptide (pmol/L)
0.264
White cell count (109/L)
0.411
Lymphoid cell count (109/L)
0.695
Neutrophil count (109/L)a
3.41 (3.12~3.50)
3.42 (2.88~3.68)
0.878
Mononuclear count (109/L)
0.095
Data are expressed by or median (25-75th percentile). BMI: body mass index; WHR: waist to hip ratio; DBP: diastolic blood pressure; SBP: systolic blood pressure; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; acompared by the Mann-Whitney test. compared with HC. compared with HC. compared with HC.
